BACK TO MAIN SITE
 
AGING NEWS
Alzheimers
Arthritis
Bone Disease
Cancer
Cholesterol
Diabetes
Erectile Dysfunction
Heart Disease
Liver Disease
Lung Cancer
Parkinsons
Prostate Disease
Strokes
 
ANTIAGING NEWS
Cosmetic Surgery
Environmental
Hormone Therapy
 
WELLNESS NEWS
Fitness & Diet
Mental Wellbeing
Mens Health
Senior Health
Smoking
Womens Health
 
PRODUCT NEWS
FDA Product Alerts
 
TREATMENT NEWS
Cosmetic Surgery
 
EYESIGHT NEWS
HEARING NEWS
DENTISTRY NEWS
RESEARCH NEWS
Alternative Medicine
Clinical Trials
FDA Updates
Stem Cell Research

LATEST NEWS ON EYESIGHT

 

The latest news on eyesight support, research and treatments from Medical News Today.com

The Brain Needs To Remember Faces In 3-Dimensions

In our dynamic 3D world, we can encounter a familiar face from any angle and still recognize that face with ease, even if the person has, for example, changed his hair style. This is because our brain has used the 2D snapshots perceived by our eyes (like a camera) to build and store a 3D mental representation of the face, which is resilient to such changes...
09/10/2010


ReVision Optics Finishes Phase One Of FDA Clinical Trial

ReVision Optics (RVO), a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion...
09/10/2010


Detecting Mad Cow Disease Via The Eyes Of Cattle

The eyes may or may not be windows to the soul, as the old adage goes, but scientists are reporting evidence that a peek into the eyes of cattle may become the basis for a long-sought test to detect infection with the agent that causes Mad Cow Disease. That test could help prevent the disease from spreading in the food supply...
09/10/2010


Promedior Announces Initiation Of Phase 2a Of Anti-Fibrotic Therapeutic, PRM-151, In The Prevention Of Post-Surgical Scarring In Glaucoma Patients

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery...
09/09/2010


Can-Fite BioPharma Announces The Initiation Of Phase 3 In Dry Eye Syndrome

Can-Fite BioPharma Ltd (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened an Investigational New Drug application (IND) with the US-FDA for a Phase 3 study of its lead drug, CF101, in patients with moderate to severe Dry Eye Syndrome...
09/08/2010


ThromboGenics Presents Positive Pooled Results From The MIVI-TRUST Phase III Program

ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that the pooled results from the successful microplasmin MIVI-TRUST Phase III program were presented today at the EURETINA (European Society of Retina Specialists) Congress in Paris, France...
09/07/2010


American Academy Of Ophthalmology Joins Forces With Middle East Africa Council Of Ophthalmology For Joint Meeting In Chicago October 16 To 19

The largest and most comprehensive ophthalmic educational meeting in the world, the American Academy of Ophthalmology's (Academy) 2010 Joint Meeting in conjunction with the Middle East Africa Council of Ophthalmology (MEACO) will be taking place in Chicago, October 16 to 19...
09/06/2010


Stem Cell Ruling Halts Sight-Saving Research

The Association for Research in Vision and Ophthalmology (ARVO), a professional organization of member scientists, opposes the Federal District Court injunction that froze federal funding for human embryonic stem cell (hESC) research. ARVO is troubled by this barrier to research that has the potential to restore sight and mitigate eye damage...
09/06/2010


Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside The United States

Alcon, Inc. (NYSE: ACL), the world's leader in eye care and cataract surgery, announced its launch of the AcrySof® IQ ReSTOR® Multifocal Toric intraocular lens (IOL) outside the United States during the 2010 European Society of Cataract and Refractive Surgeons (ESCRS) annual meeting in Paris, France...
09/05/2010


Starting The School Year Right

As many children head back to school this fall, are they truly prepared for what lies ahead? With a few simple medical exams; Maine's school-age children will be armed with the tools they need to have a healthier school year...
09/04/2010


Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium

Twenty-first-century pharmaceutical breakthroughs require 21st-century drug discovery tools, such as computational or in silico molecular design and high-throughput screening of effective, new compounds. That's the theme of a University at Buffalo symposium to be held Sept...
09/03/2010


'Back-To-School' How To Prevent Sports Related Eye Injuries

It's back to school time! Kids are feeling excited and maybe a little nervous. New teachers, new friends and new sports seasons. Parents are scrambling to buy back-to-school clothes and equip their children with all the sports gear they need, like helmets, pads, braces and mouth guards...
09/03/2010


Carl Zeiss Meditec Is Shaping The Future Of Ophthalmology: Creating What's To Come

Carl Zeiss Meditec is once again presenting its expanded offer of solutions for cataract, refractive and retina applications. Under the theme - Creating what's to come - the company is demonstrating how it would like to shape the future of ophthalmology with its products and solutions...
09/03/2010


OptiMedica's Laser Cataract Surgery System To Be Featured In Three Clinical Presentations At ESCRS 2010

Global ophthalmic device company OptiMedica Corp. has announced that clinical results for its laser cataract surgical system will be the subject of three presentations at the European Society of Cataract and Refractive Surgeons annual meeting in Paris, September 4 - 8...
09/03/2010


Dr. Tom Tooma Purchases Interest In All 12 Southern California TLC Laser Eye Centers, Changing Name To NVISION Laser Eye Centers

All 12 TLC Laser Eye Centers in Southern California are changing their names to NVISION Laser Eye Centers. The name change accompanies the sale of TLC Vision's interest in the 12 centers to Medical Director Dr. Tom Tooma to become a separate LASIK brand. The new brand will operate as NVISION Laser Eye Centers and will have the same 12 Southern California locations, same surgeons and staff...
09/02/2010



Return to Top

 
Bookmark and Share

GET LATEST ANTIAGING
PRODUCT NEWS & REVIEWS

Email:
Name:

 
 
 
Articles Archive Blog Forum Shopping Catalogue Site Map Contact Us Antiaging Wellness Latest News Antiaging Article Index Antiaging Wellness Blog Antiaging Wellness Forum Shop For Antiaging & Wellness Products Antiaging Wellness Site Support